ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · IEX Real-Time Price · USD
19.03
+0.26 (1.39%)
Jul 22, 2024, 10:21 AM EDT - Market open
ArriVent BioPharma Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$29.25
Upside
+53.70%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +31.37% | Jun 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +31.37% | May 9, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $25 | Strong Buy | Initiates | $25 | +31.37% | Apr 30, 2024 |
| Citigroup | Citigroup | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +57.65% | Feb 20, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $35 | Strong Buy | Initiates | $35 | +83.92% | Feb 20, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Initiates $27 | Strong Buy | Initiates | $27 | +41.88% | Feb 20, 2024 |